Clinical Trials Directory

Trials / Completed

CompletedNCT03748108

Bolus Administration of Intravenous Lidocaine at the Time of Abdominal Hysterectomy

A Randomized Clinical Trial Estimating the Efficacy of Bolus Administration of Intravenous Lidocaine at the Time of Abdominal Hysterectomy to Decrease Postoperative Pain

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
120 (actual)
Sponsor
Aswan University Hospital · Academic / Other
Sex
Female
Age
35 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The objective of the study to evaluate whether a bolus administration of intravenous lidocaine decreases postoperative pain and represents an opioid-minimizing strategy after abdominal hysterectomy compared with placebo.

Detailed description

Total abdominal hysterectomy (TAH) is the most common gynecological operation worldwide. Some studies noticed about abused of opioids in postoperative care, led to a more adverse effect of opioids, slow recovery, prolong the length of hospitalized stay and consequently increase the unnecessary cost of treatment. Guidelines have considered using preoperative analgesics for reducing post-operative opioids consumption, including lidocaine infusion. With its anti-inflammatory, anti-hyperalgesia and analgesic properties, intravenous perioperative lidocaine infusion (IVLI) has been used for optimal postoperative care in different surgeries and in various procedures involving hysterectomy. Therefore, the aim of this study is to assess the efficacy of bolus administration of intravenous lidocaine at the time of abdominal hysterectomy to decrease postoperative pain and reducing morphine requirements, after TAH.

Conditions

Interventions

TypeNameDescription
DRUGlidocainea bolus intravenous dose of 1.5 mg/kg lidocaine 2% over 15 s just before the induction of general anesthesia.
DRUGPlaceboa bolus intravenous dose of 1.5 mg/ kg a saline placebo over 15 s just before the induction of general anesthesia.

Timeline

Start date
2018-12-01
Primary completion
2020-03-30
Completion
2020-08-01
First posted
2018-11-20
Last updated
2020-08-05

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT03748108. Inclusion in this directory is not an endorsement.